Published in TB and Outbreaks Week, June 9th, 1997
Researcher Afranio L. Kritski and colleagues also found these variables to be important predictors of adverse outcomes in retreated patients.
"Our present study suggests that clinical outcomes and the likelihood of development of multidrug-resistant tuberculosis (MDR-TB) may be predicted by grouping previously treated patients into those who abandon treatment or suffer relapse after treatment,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.